6/5/13 Flashcards Preview

STEP II > 6/5/13 > Flashcards

Flashcards in 6/5/13 Deck (20):
1

What is the mechanism of α-blockers in benign prostatic hyperplasia?

relax urethral sphincter

2

What are the best hypertensive choices for pts w/ chronic kidney failure?

ACE-Is and ARBs

3

What causes black pigment stones in the gallbladder?

hemolysis

4

What causes brown pigment stones in the gallbladder?

chronic infection, esp. parasitic

5

In any acute spinal injury or compression of any process, the first intervention should be ______.

hi-dose IV steroids

6

What is the next best step for suspected cord compression after steroids?

MRI

7

How long is the max. delay allowed for choosing PCI over thrombolytics for AMI?

90 mins

8

What is the inheritance pattern of hereditary spherocytosis?

AD

9

What vitamin should be supplemented in pts w/ hereditary spherocytosis?

folate

10

What is the best medication for slowing the progression of diabetic nephropathy in all pts, whether or not they have htn?

ACE-Is

11

What is the major cause of mortality in TCA overdose?

hypotension

12

What should be administered to pts of TCA overdose to combat hypotension, prolonged QT interval, and arrhythmia?

sodium bicarb

13

What should be infused into pts suffering from torsade de pointes?

Mg sulfate

14

What is the initial treatment of anal fissure?

dietary modification, stool softeners, and local anesthetic

15

Define "salvage therapy".

A form of therapy used after standard therapy as failed.

16

How is induction therapy different from neoadjuvant?

induction may or may not be followed by another tx (e.g. surgery)

17

What is the other name of herceptin, the monoclonal Ab that targets the HER2 receptor?

trastuzumab

18

What is resistance, a psychological defense mechanism?

refusal to bring an unpleasant unconscious thought to awareness

19

What electrolyte abnormality is a common complication of subarachnoid hemorrhage?

hyponatremia - "cerebral salt-wasting syndrome"

20

What are the two main mediators of cerebral salt-wasting syndrome following SAH?

vasopressin and Atrial/brain natriuretic peptide